Genome-wide analysis of STAT target genes - Elucidating the mechanism of STAT-mediated oncogenesis

被引:91
作者
Alvarez, JV
Frank, DA
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
STAT3; STAT5; STAT; transcription factor; cancer; oncogenesis; microarray; expression profiling;
D O I
10.4161/cbt.3.11.1172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inappropriate activation of transcription factors is a common event in cancer. These transcription factors contribute to a malignant phenotype by regulating genes involved in cellular proliferation, survival, differentiation, angiogenesis, and invasion. An important goal remains identifying the targets of oncogenic transcription factors that execute these changes. STAT proteins are among the best-studied of these transcription factors, and are involved in oncogenesis both in vivo and in vitro. They thus represent an ideal model for understanding how transcription factors cause cancer through coordinated changes in gene expression. Recent studies have employed microarray-based expression analysis to comprehensively identify STAT target genes. Analysis of these targets can provide insight into mechanisms of neoplastic transformation, and may shed light on new strategies for targeted therapy.
引用
收藏
页码:1045 / 1050
页数:6
相关论文
共 55 条
  • [1] Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
    Aoki, Y
    Feldman, GM
    Tosato, G
    [J]. BLOOD, 2003, 101 (04) : 1535 - 1542
  • [2] Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
    Bowman, T
    Broome, MA
    Sinibaldi, D
    Wharton, W
    Pledger, WJ
    Sedivy, JM
    Irby, R
    Yeatman, T
    Courtneidge, SA
    Jove, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7319 - 7324
  • [3] STATs in oncogenesis
    Bowman, T
    Garcia, R
    Turkson, J
    Jove, R
    [J]. ONCOGENE, 2000, 19 (21) : 2474 - 2488
  • [4] Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation
    Brocke-Heidrich, K
    Kretzschmar, AK
    Pfeifer, G
    Henze, C
    Löffler, D
    Koczan, D
    Thiesen, HJ
    Burger, R
    Gramatzki, M
    Horn, F
    [J]. BLOOD, 2004, 103 (01) : 242 - 251
  • [5] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [6] Stat3 activation is required for cellular transformation by v-src
    Bromberg, JF
    Horvath, CM
    Besser, D
    Lathem, WW
    Darnell, JE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) : 2553 - 2558
  • [7] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    [J]. IMMUNITY, 1999, 10 (01) : 105 - 115
  • [8] SOCS1 and SHP1 hypermethylation in multiple myeloma:: implications for epigenetic activation of the Jak/STAT pathway
    Chim, CS
    Fung, TK
    Cheung, WC
    Liang, R
    Kwong, YL
    [J]. BLOOD, 2004, 103 (12) : 4630 - 4635
  • [9] Transcription factors as targets for cancer therapy
    Darnell, JE
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 740 - 749
  • [10] STATs and gene regulation
    Darnell, JE
    [J]. SCIENCE, 1997, 277 (5332) : 1630 - 1635